Kruti Patel

Title: Innovations in Vaccine Development by Kruti Patel

Introduction

Kruti Patel is an accomplished inventor based in North Dartmouth, MA (US). She has made significant contributions to the field of vaccine development, particularly in the context of COVID-19. Her innovative approach combines established vaccine platforms with novel techniques to enhance immunization efficacy.

Latest Patents

Kruti Patel holds a patent for a groundbreaking invention titled "Tetanus vaccine platform for embedding COVID-19 vaccine." This patent describes a recombinant SARS-CoV2 protein-based vaccine and a method of immunizing that involves embedding epitopes or chemically attaching them to a detoxified recombinant tetanus neurotoxin (DrTeNT). The developed vaccine aims to provide a novel and effective platform for immunization against SARS-CoV2, with three key contributions: a new vaccine platform, improved host immune response through priming with DrTeNT, and the potential for oral delivery using neurotoxin binding proteins (NAPs). The DrTeNT candidate is designed to be risk-free, devoid of formalin or other chemical adjuvants.

Career Highlights

Kruti Patel is currently employed at Prime Bio, Inc., where she continues to advance her research in vaccine technology. Her work has garnered attention for its innovative approach to addressing public health challenges, particularly during the ongoing pandemic.

Collaborations

She collaborates with notable colleagues, including Bal Ram Singh and Raj Kumar, who contribute to her research efforts and the development of her patented technologies.

Conclusion

Kruti Patel's innovative work in vaccine development exemplifies the potential of combining established technologies with new methodologies to create effective solutions for global health issues. Her contributions are paving the way for advancements in immunization strategies against COVID-19 and beyond.